{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:48:23Z","timestamp":1776872903660,"version":"3.51.2"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,27]]},"DOI":"10.7759\/cureus.59133","type":"journal-article","created":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T11:29:04Z","timestamp":1714217344000},"source":"Crossref","is-referenced-by-count":1,"title":["Comparison of Pre-eclampsia Screening Algorithms in the First Trimester of Pregnancy Being Used in Thai Nguyen Province"],"prefix":"10.7759","author":[{"given":"Luong  T","family":"Huong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le Thi  h","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ha Thi V","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nguyen v","family":"Cuong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.31143","article-title":"Preeclampsia incidence and its maternal and neonatal outcomes with associated risk factors","volume":"14","author":"Khan B","year":"2022","unstructured":"Khan B, Allah Yar R, Khakwani AK, Karim S, Arslan Ali H. Preeclampsia incidence and its maternal and neonatal outcomes with associated risk factors. Cureus. 2022, 14:e31143. 10.7759\/cureus.31143","journal-title":"Cureus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.8401","article-title":"Preeclampsia prevalence, risk factors, and pregnancy outcomes in Sweden and China","volume":"4","author":"Yang Y","year":"2021","unstructured":"Yang Y, Le Ray I, Zhu J, Zhang J, Hua J, Reilly M. Preeclampsia prevalence, risk factors, and pregnancy outcomes in Sweden and China. JAMA Netw Open. 2021, 4:e218401. 10.1001\/jamanetworkopen.2021.8401","journal-title":"JAMA Netw Open"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60686-8","article-title":"Moving beyond essential interventions for reduction of maternal mortality (the WHO Multicountry Survey on Maternal and Newborn Health): a cross-sectional study","volume":"381","author":"Souza JP","year":"2013","unstructured":"Souza JP, G\u00fclmezoglu AM, Vogel J, et al.. Moving beyond essential interventions for reduction of maternal mortality (the WHO Multicountry Survey on Maternal and Newborn Health): a cross-sectional study. Lancet. 2013, 381:1747-55. 10.1016\/S0140-6736(13)60686-8","journal-title":"Lancet"},{"key":"ref4","article-title":"Studying the results of screening for preeclampsia - eclampsia using PAPP-A test, uterine artery doppler and the effectiveness of preventive treatment","author":"Linh TM","unstructured":"Linh TM . Studying the results of screening for preeclampsia - eclampsia using PAPP-A test, uterine artery doppler and the effectiveness of preventive treatment."},{"key":"ref5","article-title":"Study on the effectiveness of preventive treatment of preeclampsia - eclampsia with calcium in pregnant women at high risk of preeclampsia - eclampsia (Article in Vietnamese)","volume":"13","author":"Vinh TQ","unstructured":"Vinh TQ, Yucheng G, Huy NVQ, Duc VV, Diem Thu NT, Linh TM. Study on the effectiveness of preventive treatment of preeclampsia - eclampsia with calcium in pregnant women at high risk of preeclampsia - eclampsia (Article in Vietnamese). Vietnamese Journal of obstetrics and gynecology. 13:54-61.","journal-title":"Vietnamese Journal of obstetrics and gynecology"},{"key":"ref6","article-title":"Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation","volume":"103","author":"O\u2019Gorman N","unstructured":"O\u2019Gorman N, Wright D, Syngelaki A.. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation. Am J Obstet Gynecol. 103:1-103.","journal-title":"Am J Obstet Gynecol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/uog.17455","article-title":"Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations","volume":"49","author":"O'Gorman N","year":"2017","unstructured":"O'Gorman N, Wright D, Poon LC, et al.. Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations. Ultrasound Obstet Gynecol. 2017, 49:756-60. 10.1002\/uog.17455","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/uog.18816","article-title":"ASPRE trial: performance of screening for preterm pre-eclampsia","volume":"50","author":"Rolnik DL","year":"2017","unstructured":"Rolnik DL, Wright D, Poon LC, et al.. ASPRE trial: performance of screening for preterm pre-eclampsia. Ultrasound Obstet Gynecol. 2017, 50:492-5. 10.1002\/uog.18816","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.12802","article-title":"The International Federation of Gynecology and Obstetrics (FIGO) initiative on preeclampsia (PE): a pragmatic guide for first trimester screening and prevention","volume":"145","author":"Poon LC","year":"2019","unstructured":"Poon LC, Shennan A, Hyett JA, et al.. The International Federation of Gynecology and Obstetrics (FIGO) initiative on preeclampsia (PE): a pragmatic guide for first trimester screening and prevention. Int J Gynaecol Obstet. 2019, 145:1-33. 10.1002\/ijgo.12802","journal-title":"Int J Gynaecol Obstet"},{"key":"ref10","unstructured":"Assessment of risk for preeclampsia . Accessed. April 2024: https:\/\/fetalmedicine.org\/research\/assess\/preeclampsia\/background%3E,%20accessed:%2003\/22\/2024."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/uog.19039","article-title":"Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE","volume":"51","author":"Tan MY","year":"2018","unstructured":"Tan MY, Wright D, Syngelaki A, et al.. Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE. Ultrasound Obstet Gynecol. 2018, 51:743-50. 10.1002\/uog.19039","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref12","unstructured":"Hypertension in pregnancy. diagnosis and management. (2019). Accessed: April 2024: https:\/\/www.nice.org.uk\/guidance\/ng133\/chapter\/Recommendations."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.17598","article-title":"First trimester screening for pre-eclampsia and targeted aspirin prophylaxis: a cost-effectiveness cohort study","volume":"131","author":"Nzelu D","year":"2024","unstructured":"Nzelu D, Palmer T, Stott D, et al.. First trimester screening for pre-eclampsia and targeted aspirin prophylaxis: a cost-effectiveness cohort study. BJOG. 2024, 131:222-30. 10.1111\/1471-0528.17598","journal-title":"BJOG"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6414857","article-title":"Effectiveness of different algorithms and cut-off value in preeclampsia first trimester screening","volume":"2022","author":"Tousty P","year":"2022","unstructured":"Tousty P, Czuba B, Borowski D, et al.. Effectiveness of different algorithms and cut-off value in preeclampsia first trimester screening. J Pregnancy. 2022, 2022:6414857. 10.1155\/2022\/6414857","journal-title":"J Pregnancy"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/uog.22093","article-title":"Screening for pre-eclampsia at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both","volume":"56","author":"Mazer Zumaeta A","year":"2020","unstructured":"Mazer Zumaeta A, Wright A, Syngelaki A, Maritsa VA, Da Silva AB, Nicolaides KH. Screening for pre-eclampsia at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both. Ultrasound Obstet Gynecol. 2020, 56:400-7. 10.1002\/uog.22093","journal-title":"Ultrasound Obstet Gynecol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/243728-comparison-of-pre-eclampsia-screening-algorithms-in-the-first-trimester-of-pregnancy-being-used-in-thai-nguyen-province","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T11:29:10Z","timestamp":1714217350000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/243728-comparison-of-pre-eclampsia-screening-algorithms-in-the-first-trimester-of-pregnancy-being-used-in-thai-nguyen-province"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,27]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.59133","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,27]]}}}